#RosaceaMonth

According to a study in JAMA Dermatology, prescribing rates of #spironolactone for #acne in women rose by nearly 300% from 2017 to 2020...
nbcnews.com/health/health-…

John Barbieri, MD, MBA
Jessica Krant MD
Ayman Grada, MD, MHA

#yourdermatologistknows

What's up with #spironolactone ? 💊

In part 2 of Healio's Beneath the Surface series, Joel M Gelfand MD MSCE FAAD and John Barbieri, MD, MBA are back to discuss spironolactone's place in #acne management 🔽

healio.com/news/dermatolo…

#DermWorld interviews John Barbieri, MD, MBA, co-chair of the Academy’s Acne Guidelines Workgroup, about important changes to the #iPLEDGE program. aad.org/dw/monthly/202…

While dryness is the most common side effect from isotretinoin (Accutane), there is much we can do to help prevent and treat:
youtu.be/u-DvuI9AhG0

Had a great time discussing How to Use Antibiotics and Isotretinoin for Acne with Dr. Jim Del Rosso and Dr. Emmy Graber. Check it out on VuMedi:
vumedi.com/video/how-to-u…
Brigham and Women’s Dermatology Dermatology Boston

📹 Healio Dermatology is proud to announce the launch of Beneath the Surface — a video series in which our Chief Medical Editor, Joel M Gelfand MD MSCE FAAD, discusses hot topics in the field with leading experts.

Check out our first interview with John Barbieri, MD, MBA 🔽
healio.com/news/dermatolo…

Enjoyed participating with Joel Gelfand in the inaugural edition of Beneath the Surface: Exploring the new AAD acne guidelines.
Healio Dermatology Brigham and Women’s Dermatology
healio.com/news/dermatolo…

The Skindex-16 is an efficient quality of life measure for use in both clinical trials and practice. In this study, we demonstrate the internal consistency, structural validity, and construct validity of the Skindex-16 among individuals with acne (n=170).
sciencedirect.com/science/articl…

Our first workgroup update comes from Acne Workgroup Chair John Barbieri, MD, MBA, who will present, 'Acne - ACORN.' Dr. Barbieri is a dermatologist and epidemiologist at Brigham and Women's Hospital (@bwhdermatology).

#IDEOMEvents #DermTwitter #Dermatology #Epidemiology #Psoriasis

New RCT of desloratadine + isotretinoin 0.3mg/kg/day vs isotretinoin alone, finding higher satisfaction in the combination group, but no differences in rate of clearance or flaring (though rates of flaring were low; ~10% with this low dose regimen).
pubmed.ncbi.nlm.nih.gov/38546101/

Interesting paper describing rationale for considering carbolic acid (phenol) rather than TCA when doing the CROSS technique for ice pick and boxcar atrophic acne scarring. Some good diagrams of how to do the CROSS technique as well.
pubmed.ncbi.nlm.nih.gov/38547386/

Every #dermtwitter trainee should watch this video on #acne — answers a lot of common questions and addresses a ton of debated topics.

This week, I'm taking a bit of a different approach, sharing a more lecture style video discussing some interesting controversies in acne and rosacea (based on my talk at the recent American Academy of Dermatology meeting). Check it out!
youtu.be/35H4aw21cr4